Miguel Angel Avila Santiago

Miguel Angel Avila Santiago is a seasoned professional with extensive experience in biotechnology, innovation, and education. Currently serving as General Director and Co-Founder at ViroFend S.L. and President, CEO & Co-founder of Neurofix Pharma S.A., Miguel leads initiatives in developing innovative therapies for Central Nervous System pathologies. Miguel's roles also include Managing Director & Co-founder at Ayuntamiento de Salamanca, adviser on biotech strategy, and mentor at Universidad de Salamanca, where contributions to research excellence are prioritized. As a writer, Miguel has penned several works, including novels and guides on local natural resources. Academic qualifications include degrees from Universidad de Salamanca, INESEM Business School, and additional training in project management and clinical practices, reflecting a diverse skill set aimed at advancing both business and community ventures.